CVE Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Cenovus Energy Inc (CVE) is a good buy for a beginner investor with a long-term investment strategy and $50,000-$100,000 available. The stock shows strong financial performance, bullish technical indicators, and positive sentiment from analysts, despite some recent downgrades. The options data and stock trend analysis further support a favorable outlook.
The stock's technical indicators are bullish overall. The moving averages (SMA_5 > SMA_20 > SMA_200) indicate an upward trend. RSI is neutral at 69.511, suggesting no overbought or oversold conditions. The MACD histogram is negative but contracting, which may signal a potential reversal to positive momentum. The stock closed above its pivot point (22.476) and is approaching resistance levels (R1: 23.32, R2: 23.842), indicating strength.
Strong financial performance in Q4 2025, with net income up 580.29% YoY and EPS up 614.29% YoY.
Positive analyst sentiment, with multiple firms raising price targets to C$32-C$35 and maintaining Buy or Outperform ratings.
Bullish technical indicators and favorable stock trend analysis, with a 70% chance of a 5.62% gain in the next week and 8.53% in the next month.
Veritas downgraded the stock to Sell with a C$27 price target.
JPMorgan downgraded the stock to Neutral, citing relative valuations and preference for U.S. majors over Canadian integrateds.
Revenue dropped by 7.35% YoY in Q4 2025, which may raise concerns about top-line growth.
In Q4 2025, Cenovus Energy demonstrated strong financial performance despite a revenue decline of 7.35% YoY. Net income surged by 580.29% YoY to $932 million, EPS increased by 614.29% YoY to 0.5, and gross margin improved by 11.09% YoY to 25.24%. These metrics indicate significant profitability and operational efficiency improvements.
Analyst sentiment is mixed but leans positive. RBC Capital, BMO Capital, and TD Securities raised price targets to C$32-C$35 with Buy or Outperform ratings, citing strong leadership, free cash flow generation, and portfolio enhancements. However, Veritas downgraded the stock to Sell, and JPMorgan downgraded it to Neutral, citing valuation concerns and preference for U.S. majors.
